AdvaMed selects MTI institute leader
This article was originally published in The Gray Sheet
Executive Summary
Trade group taps former University of Texas M.D. Anderson Cancer Center VP-International Business Development & Chief Marketing Officer Martyn Howgill to serve as executive director of its newly created Institute for Medical Technology Innovation (1"The Gray Sheet" March 8, 2004, p. 30). Member companies have contributed nearly $12.5 mil. to support the research and education body...You may also be interested in...
Patient Access, Med Tech Value Research Top Collins’ Goals For AdvaMed
EU Ministers Want Decisive Action On Medicines Access & Shortages
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
Bio-Thera Gets Chinese Nod To Proceed On Ustekinumab
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: